Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target

Azin Nezami, Irene Luque, Tooru Kimura, Yoshiaki Kiso, Ernesto I Freire

Research output: Contribution to journalArticle

Abstract

Plasmepsin II is a key enzyme in the life cycle of the Plasmodium parasites responsible for malaria, a disease that afflicts more than 300 million individuals annually. Since plasmepsin II inhibition leads to starvation of the parasite, it has been acknowledged as an important target for the development of new antimalarials. In this paper, we identify and characterize high-affinity inhibitors of plasmepsin II based upon the allophenylnorstatine scaffold. The best compound, KNI-727, inhibits plasmepsin II with a Ki of 70 nM and a 22-fold selectivity with respect to the highly homologous human enzyme cathepsin D. KNI-727 binds to plasmepsin II in a process favored both enthalpically and entropically. At 25°C, the binding enthalpy (ΔH) is -4.4 kcal/mol and the entropic contribution (-TΔS) to the Gibbs energy is -5.56 kcal/mol. Structural stability measurements of plasmepsin II were also utilized to characterize inhibitor binding. High-sensitivity differential scanning calorimetry experiments performed in the absence of inhibitors indicate that, at pH 4.0, plasmepsin II undergoes thermal denaturation at 63.3°C. The structural stability of the enzyme increases with inhibitor concentration in a manner for which the binding energetics of the inhibitor can quantitatively account. The effectiveness of the best compounds in killing the malaria parasite was validated by performing cytotoxicity assays in red blood cells infected with Plasmodium falciparum. EC50s ranging between 6 and 10 μM (3-6 μg/mL) were obtained. These experiments demonstrate the viability of the allophenylnorstatine scaffold in the design of powerful and selective plasmepsin inhibitors.

Original languageEnglish (US)
Pages (from-to)2273-2280
Number of pages8
JournalBiochemistry®
Volume41
Issue number7
DOIs
StatePublished - Feb 19 2002

Fingerprint

Antimalarials
Parasites
Scaffolds
Malaria
Enzymes
Enzyme Stability
Cathepsin D
Denaturation
Plasmodium
Differential Scanning Calorimetry
Gibbs free energy
Plasmodium falciparum
Cytotoxicity
Starvation
3-amino-2-hydroxy-4-phenylbutanoic acid
plasmepsin II
Life Cycle Stages
Life cycle
Differential scanning calorimetry
Enthalpy

ASJC Scopus subject areas

  • Biochemistry

Cite this

Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target. / Nezami, Azin; Luque, Irene; Kimura, Tooru; Kiso, Yoshiaki; Freire, Ernesto I.

In: Biochemistry®, Vol. 41, No. 7, 19.02.2002, p. 2273-2280.

Research output: Contribution to journalArticle

Nezami, Azin ; Luque, Irene ; Kimura, Tooru ; Kiso, Yoshiaki ; Freire, Ernesto I. / Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target. In: Biochemistry®. 2002 ; Vol. 41, No. 7. pp. 2273-2280.
@article{dcecbc3b2e7348849741523e7914853b,
title = "Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target",
abstract = "Plasmepsin II is a key enzyme in the life cycle of the Plasmodium parasites responsible for malaria, a disease that afflicts more than 300 million individuals annually. Since plasmepsin II inhibition leads to starvation of the parasite, it has been acknowledged as an important target for the development of new antimalarials. In this paper, we identify and characterize high-affinity inhibitors of plasmepsin II based upon the allophenylnorstatine scaffold. The best compound, KNI-727, inhibits plasmepsin II with a Ki of 70 nM and a 22-fold selectivity with respect to the highly homologous human enzyme cathepsin D. KNI-727 binds to plasmepsin II in a process favored both enthalpically and entropically. At 25°C, the binding enthalpy (ΔH) is -4.4 kcal/mol and the entropic contribution (-TΔS) to the Gibbs energy is -5.56 kcal/mol. Structural stability measurements of plasmepsin II were also utilized to characterize inhibitor binding. High-sensitivity differential scanning calorimetry experiments performed in the absence of inhibitors indicate that, at pH 4.0, plasmepsin II undergoes thermal denaturation at 63.3°C. The structural stability of the enzyme increases with inhibitor concentration in a manner for which the binding energetics of the inhibitor can quantitatively account. The effectiveness of the best compounds in killing the malaria parasite was validated by performing cytotoxicity assays in red blood cells infected with Plasmodium falciparum. EC50s ranging between 6 and 10 μM (3-6 μg/mL) were obtained. These experiments demonstrate the viability of the allophenylnorstatine scaffold in the design of powerful and selective plasmepsin inhibitors.",
author = "Azin Nezami and Irene Luque and Tooru Kimura and Yoshiaki Kiso and Freire, {Ernesto I}",
year = "2002",
month = "2",
day = "19",
doi = "10.1021/bi0117549",
language = "English (US)",
volume = "41",
pages = "2273--2280",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target

AU - Nezami, Azin

AU - Luque, Irene

AU - Kimura, Tooru

AU - Kiso, Yoshiaki

AU - Freire, Ernesto I

PY - 2002/2/19

Y1 - 2002/2/19

N2 - Plasmepsin II is a key enzyme in the life cycle of the Plasmodium parasites responsible for malaria, a disease that afflicts more than 300 million individuals annually. Since plasmepsin II inhibition leads to starvation of the parasite, it has been acknowledged as an important target for the development of new antimalarials. In this paper, we identify and characterize high-affinity inhibitors of plasmepsin II based upon the allophenylnorstatine scaffold. The best compound, KNI-727, inhibits plasmepsin II with a Ki of 70 nM and a 22-fold selectivity with respect to the highly homologous human enzyme cathepsin D. KNI-727 binds to plasmepsin II in a process favored both enthalpically and entropically. At 25°C, the binding enthalpy (ΔH) is -4.4 kcal/mol and the entropic contribution (-TΔS) to the Gibbs energy is -5.56 kcal/mol. Structural stability measurements of plasmepsin II were also utilized to characterize inhibitor binding. High-sensitivity differential scanning calorimetry experiments performed in the absence of inhibitors indicate that, at pH 4.0, plasmepsin II undergoes thermal denaturation at 63.3°C. The structural stability of the enzyme increases with inhibitor concentration in a manner for which the binding energetics of the inhibitor can quantitatively account. The effectiveness of the best compounds in killing the malaria parasite was validated by performing cytotoxicity assays in red blood cells infected with Plasmodium falciparum. EC50s ranging between 6 and 10 μM (3-6 μg/mL) were obtained. These experiments demonstrate the viability of the allophenylnorstatine scaffold in the design of powerful and selective plasmepsin inhibitors.

AB - Plasmepsin II is a key enzyme in the life cycle of the Plasmodium parasites responsible for malaria, a disease that afflicts more than 300 million individuals annually. Since plasmepsin II inhibition leads to starvation of the parasite, it has been acknowledged as an important target for the development of new antimalarials. In this paper, we identify and characterize high-affinity inhibitors of plasmepsin II based upon the allophenylnorstatine scaffold. The best compound, KNI-727, inhibits plasmepsin II with a Ki of 70 nM and a 22-fold selectivity with respect to the highly homologous human enzyme cathepsin D. KNI-727 binds to plasmepsin II in a process favored both enthalpically and entropically. At 25°C, the binding enthalpy (ΔH) is -4.4 kcal/mol and the entropic contribution (-TΔS) to the Gibbs energy is -5.56 kcal/mol. Structural stability measurements of plasmepsin II were also utilized to characterize inhibitor binding. High-sensitivity differential scanning calorimetry experiments performed in the absence of inhibitors indicate that, at pH 4.0, plasmepsin II undergoes thermal denaturation at 63.3°C. The structural stability of the enzyme increases with inhibitor concentration in a manner for which the binding energetics of the inhibitor can quantitatively account. The effectiveness of the best compounds in killing the malaria parasite was validated by performing cytotoxicity assays in red blood cells infected with Plasmodium falciparum. EC50s ranging between 6 and 10 μM (3-6 μg/mL) were obtained. These experiments demonstrate the viability of the allophenylnorstatine scaffold in the design of powerful and selective plasmepsin inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=0037133223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037133223&partnerID=8YFLogxK

U2 - 10.1021/bi0117549

DO - 10.1021/bi0117549

M3 - Article

C2 - 11841219

AN - SCOPUS:0037133223

VL - 41

SP - 2273

EP - 2280

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 7

ER -